Jun 5, 2024 | Featured, Maryland, News, Science
Disulfiram (aka, Antabuse), a drug approved by the US Food & Drug Administration (FDA) for deterring alcohol consumption, has moved into a clinical trial for potentially improving vision in people with retinitis pigmentosa (RP). The 30-participant,...
May 30, 2024 | Media, News, Science, YouTube
The Foundation Fighting Blindness’ quarterly Insights Forum provides updates on the progress on the Foundation’s mission-related initiatives, highlights recent developments and provides scientific and research updates. The guest speaker for this call...
May 24, 2024 | Media, News, Podcast
Peter Wallsten, a veteran newspaper journalist and head of investigative reporting at The Washington Post, talks to host Ben Shaberman about his evolving career as a reporter and editor and the impact that Stargardt disease has had on his journey and ambitions. Peter...
May 22, 2024 | Featured, Maryland, News, Science
InGel Therapeutic’s emerging, innovative cellular treatment for preserving cone-mediated vision in people with retinitis pigmentosa (RP), Usher syndrome, and potentially other retinal conditions, was presented by Deepti Singh, PhD, InGel’s co-founder and chief...
May 22, 2024 | Media, News, Podcast
The emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing...
May 16, 2024 | Featured, News, Science
[[image-right 2230]] 14-year-old Isaiah Bingham has a calm and laid-back personality, that is, until he’s on the football field. And by watching him play, you would never know that he was diagnosed with a visual impairment at only two months old. Isaiah was born with...
